These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 38862973)
1. Adipocyte pyroptosis occurs in omental tumor microenvironment and is associated with chemoresistance of ovarian cancer. Lin CN; Liang YL; Tsai HF; Wu PY; Huang LY; Lin YH; Kang CY; Yao CL; Shen MR; Hsu KF J Biomed Sci; 2024 Jun; 31(1):62. PubMed ID: 38862973 [TBL] [Abstract][Full Text] [Related]
2. Omental Macrophagic "Crown-like Structures" Are Associated with Poor Prognosis in Advanced-Stage Serous Ovarian Cancer. Liang YL; Lin CN; Tsai HF; Wu PY; Lin SH; Hong TM; Hsu KF Curr Oncol; 2021 Oct; 28(5):4234-4246. PubMed ID: 34677277 [TBL] [Abstract][Full Text] [Related]
3. Adipocyte derived exosomes promote cell invasion and challenge paclitaxel efficacy in ovarian cancer. Williams ME; Howard D; Donnelly C; Izadi F; Parra JG; Pugh M; Edwards K; Lutchman-Sigh K; Jones S; Margarit L; Francis L; Conlan RS; Taraballi F; Gonzalez D Cell Commun Signal; 2024 Sep; 22(1):443. PubMed ID: 39285292 [TBL] [Abstract][Full Text] [Related]
4. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nieman KM; Kenny HA; Penicka CV; Ladanyi A; Buell-Gutbrod R; Zillhardt MR; Romero IL; Carey MS; Mills GB; Hotamisligil GS; Yamada SD; Peter ME; Gwin K; Lengyel E Nat Med; 2011 Oct; 17(11):1498-503. PubMed ID: 22037646 [TBL] [Abstract][Full Text] [Related]
5. Human Omental Mature Adipocytes used as Paclitaxel Reservoir for Cell-Based Therapy in Ovarian Cancer. Andele PK; Palazzolo S; Corona G; Caligiuri I; Kamensek U; Cemazar M; Canzonieri V; Rizzolio F Adv Healthc Mater; 2024 Jun; 13(15):e2304206. PubMed ID: 38334216 [TBL] [Abstract][Full Text] [Related]
6. Pro-tumoral behavior of omental adipocyte-derived fibroblasts in tumor microenvironment at the metastatic site of ovarian cancer. Iyoshi S; Yoshihara M; Nakamura K; Sugiyama M; Koya Y; Kitami K; Uno K; Mogi K; Tano S; Tomita H; Kajiwara K; Taki M; Yamaguchi S; Nawa A; Kajiyama H Int J Cancer; 2021 Dec; 149(11):1961-1972. PubMed ID: 34469585 [TBL] [Abstract][Full Text] [Related]
7. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Ladanyi A; Mukherjee A; Kenny HA; Johnson A; Mitra AK; Sundaresan S; Nieman KM; Pascual G; Benitah SA; Montag A; Yamada SD; Abumrad NA; Lengyel E Oncogene; 2018 Apr; 37(17):2285-2301. PubMed ID: 29398710 [TBL] [Abstract][Full Text] [Related]
8. Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance. Mukherjee A; Chiang CY; Daifotis HA; Nieman KM; Fahrmann JF; Lastra RR; Romero IL; Fiehn O; Lengyel E Cancer Res; 2020 Apr; 80(8):1748-1761. PubMed ID: 32054768 [TBL] [Abstract][Full Text] [Related]
11. Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC. John B; Naczki C; Patel C; Ghoneum A; Qasem S; Salih Z; Said N Oncogene; 2019 May; 38(22):4366-4383. PubMed ID: 30765860 [TBL] [Abstract][Full Text] [Related]
12. Omental Preadipocytes Stimulate Matrix Remodeling and IGF Signaling to Support Ovarian Cancer Metastasis. Waters JA; Robinson M; Lujano-Olazaba O; Lucht C; Gilbert SF; House CD Cancer Res; 2024 Jul; 84(13):2073-2089. PubMed ID: 38635891 [TBL] [Abstract][Full Text] [Related]
13. Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer. Gao L; Ying F; Cai J; Peng M; Xiao M; Sun S; Zeng Y; Xiong Z; Cai L; Gao R; Wang Z J Ovarian Res; 2023 Jan; 16(1):27. PubMed ID: 36707884 [TBL] [Abstract][Full Text] [Related]
14. Exosomes from Human Omental Adipose-Derived Mesenchymal Stem Cells Secreted into Ascites Promote Peritoneal Metastasis of Epithelial Ovarian Cancer. Qu Q; Liu L; Cui Y; Chen Y; Wang Y; Wang Y Cells; 2022 Oct; 11(21):. PubMed ID: 36359787 [TBL] [Abstract][Full Text] [Related]
16. G6PD inhibition sensitizes ovarian cancer cells to oxidative stress in the metastatic omental microenvironment. Bose S; Huang Q; Ma Y; Wang L; Rivera GO; Ouyang Y; Whitaker R; Gibson RA; Kontos CD; Berchuck A; Previs RA; Shen X Cell Rep; 2022 Jun; 39(13):111012. PubMed ID: 35767962 [TBL] [Abstract][Full Text] [Related]
17. Flavonoids Restore Platinum Drug Sensitivity to Ovarian Carcinoma Cells in a Phospho-ERK1/2-Dependent Fashion. Koren Carmi Y; Mahmoud H; Khamaisi H; Adawi R; Gopas J; Mahajna J Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32906729 [TBL] [Abstract][Full Text] [Related]
18. PARP inhibitors enhance antitumor immune responses by triggering pyroptosis via TNF-caspase 8-GSDMD/E axis in ovarian cancer. Xia Y; Huang P; Qian YY; Wang Z; Jin N; Li X; Pan W; Wang SY; Jin P; Drokow EK; Li X; Zhang Q; Zhang Z; Li P; Fang Y; Yang XP; Han Z; Gao QL J Immunother Cancer; 2024 Oct; 12(10):. PubMed ID: 39366751 [TBL] [Abstract][Full Text] [Related]
19. HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process. Ma S; Wang J; Cui Z; Yang X; Cui X; Li X; Zhao L Sci Rep; 2024 Feb; 14(1):3870. PubMed ID: 38365849 [TBL] [Abstract][Full Text] [Related]
20. Using genetically encoded fluorescent biosensors to interrogate ovarian cancer metabolism. Bose S; Yao H; Huang Q; Whitaker R; Kontos CD; Previs RA; Shen X J Ovarian Res; 2022 Oct; 15(1):114. PubMed ID: 36266675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]